(Q43811269)

English

Liarozole--a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate. Liarozole Study Group

scientific article published in July 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Liarozole--a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate. Liarozole Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

randomized experiment

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Debruyne FJ

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Murray R

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Fradet Y

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Johansson JE

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Tyrrell C

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Boccardo F

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Denis L

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Marberger JM

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Brune D

9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Rassweiler J

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Vangeneugden T

11

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Bruynseels J

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Janssens M

13

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

De Porre P

14

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

72-81

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

randomized experiment

0 references

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of Diethylstilbestrol, Cyproterone Acetate and Medroxyprogesterone Acetate in the Treatment of Advanced Prostatic Cancer: Final Analysis of a Randomized Phase III Trial of the European Organization for Research on Treatment of Cancer Urolo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyproterone Acetate in the Treatment of Advanced Carcinoma of the Prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

One hundred thirteen men with hormone-refractory prostate cancer died today

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse effects of retinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumoral effects of R 75251 on the growth of transplantable R3327 prostatic adenocarcinoma in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of survival by tumor response.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

On the relationship between response to treatment and survival time

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen and other prognostic factors in patients with hormone-resistant prostatic cancer undergoing experimental treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of prognostic factors in advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Power of logrank test and Cox regression model in clinical trials with heterogeneous samples.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical monitoring of carcinoma of prostate treated with an LH-RH analogue (Zoladex)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Early clinical experience with liarozole (Liazal) in patients with progressive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(98)00129-0

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43811269&oldid=2103549430"